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Summary 
Autologous blood transfusion is a powerful means to improve performance and remains one 
of the most challenging method to detect. Recent investigations have identified three 
candidate reticulocytes genes whose expression was significantly influenced by blood 
transfusion. Using quantitative reverse transcription polymerase chain reaction as alternative 
quantitative method, the present study supports that delta-aminolevulinate synthase 2 
(ALAS2), carbonic anhydrase (CA1) and solute carrier family 4 member 1 (SLC4A1) genes 
are down-regulated post-transfusion. The expression of these genes exhibited stronger 
correlation with immature reticulocyte fraction than with reticulocytes percentage. Moreover, 
the repression of reticulocytes’ gene expression was more pronounced than the diminution of 
immature reticulocyte fraction and reticulocyte percentage following blood transfusion. It 
suggests that the three candidate genes are reliable predictors of bone marrow’s response to 
blood transfusion and that they represent potential biomarkers for the detection of this 
method prohibited in sports. 
Keywords: Transcriptomics; Transfusion; IRF 
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Introduction 
Blood manipulations are strictly prohibited by the World Anti-Doping Agency (WADA) 
although they remain a significant problem in sports. Autologous blood transfusions (ABT) 
stand as a particular challenge for sports authorities due to the lack of direct detection 
method. ABT is currently indirectly detected with the hematological module of the Athlete 
Biological Passport (ABP) [1]. It consists in a longitudinal monitoring of various 
hematological parameters (hemoglobin level (Hb) and reticulocytes percentage (Ret%)) to 
identify suspicious patterns of altered erythropoiesis. 
Indeed, blood manipulations leave a characteristic fingerprint on the athlete’s physiology [2, 
3]. For instance, blood reinfusion suppresses erythropoiesis with a subsequent decrease of 
erythropoietin (EPO) concentration through a negative feedback system [4, 5]. It leads to a 
diminution of the release of immature red blood cells (RBCs) from the bone marrow, and 
thus a decline of Ret% and immature reticulocytes fraction (IRF). 
Based on that assumption, Salamin et al. demonstrated by a pilot study that the expression of 
genes involved in biological processes related to reticulocytes decreases following ABT 
using digital multiplex mRNA profiling [6]. These genes seemed particularly more sensitive 
to ABT than Ret%. 
The primary aim of our study was to confirm the results of this pilot study using additional 
volunteers (fifteen) and time points (eight), and quantitative reverse transcription polymerase 
chain reaction (RT-qPCR) as alternative quantitation method. Secondly, it was demonstrated 
that the expression of those genes was better correlated with IRF than with Ret%. 
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Material and methods 
Study design 
Fifteen healthy male volunteers (age range, 20-35 years; body mass index, 18-30), that were 
eligible for blood donation according to national regulations, were included in the study 
approved by the human research ethics committee of the Canton de Vaud (Switzerland; 
Protocol 06/14). Details regarding the clinical trial were previously described 
(NCT02423135) [4, 7]. Briefly, during the control phase, all volunteers were infused with 
500 mL of saline solution (NaCl 0.9%, B.Braun, Crissier Switzerland). Fourteen days later, 
all volunteers donated one full bag of blood (approximately 500 mL) using international 
standard methods of transfusion. Blood was drawn into Anticoagulant Citrate Phosphate 
Dextrose Solution, conditioned and concentrated in RBC for an approximate volume of 280 
mL. The procedure to perform RBC concentration was described in Leuenberger et al. [7]. 
The concentrated RBCs were stored at ~4°C in a solution containing saline, adenine, dextrose 
and mannitol (ADSOL preservation solution, Fenwal Laboratories, Lake Zurich, IL) until re-
infusion 36 days later. Blood samples were obtained using standard procedures from the 
antecubital vein. Blood was drawn into EDTA tubes (K2EDTA, 7.2 mg, 4 mL, BD 
Vacutainer, Plymouth, UK) and Tempus Blood RNA tubes (Life Technologies, Carlsbad, 
CA, USA) at 1 and 4 days before (baseline) and 1, 2, 3, 6, 9, and 15 days after saline infusion 
or re-infusion. 
Hematological and gene expression analyses 
The whole blood from the EDTA samples was analyzed for blood variables using a fully 
automated hematology analyzer (Sysmex XN 2000, Sysmex, Norderstedt, Germany). 
Total RNA was extracted from blood stabilized in Tempus Blood RNA Tubes using Tempus 
Spin RNA isolation kit (Life Technologies, Carlsbad, CA, USA). RNA yield was assessed 
This article is protected by copyright. All rights reserved. 
using a Qubit® 3.0 fluorometer (Life Technologies, Carlsbad, CA, USA). RNA was 
aliquoted and stored at -20°C until further analysis. 
The amount of 200 ng of extracted RNA was first reverse-transcribed into cDNA using 
Roche Transcriptor Universal cDNA Master kit (Roche Diagnostics). The resulting cDNA 
was diluted ten folds and 4 l of the diluted cDNA was used in a 10 l-PCR amplification 
reactions using specific primers of target genes (ALAS2, CA1, SLC4A1). TBP, MRFAP1, 
ACTR10 genes were selected as housekeeping genes for expression normalization from 
publicly available database. These genes were selected due to their well expression and 
stability in whole blood (mean 27 Ct). 
Statistical analyses 
Normalized data were first log2-transformed and a one-way ANOVA followed by post hoc 
pairwise comparisons (Tukey’s Honestly Significant Difference) were used to test differences 
between time points during each phase. Correlations were calculated with Pearson’s 
correlation method. Statistical analyses were performed using R software. 
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Results and discussion 
Based on the blood transcriptional signature of recombinant human EPO (rHuEPO) [8], 
Salamin et al. demonstrated that delta-aminolevulinate synthase 2 (ALAS2), carbonic 
anhydrase (CA1), and solute carrier family 4 member 1 (SLC4A1) were down-regulated after 
reinfusion of donated blood [6]. Using a different method of quantitation (RT-qPCR), we 
confirmed the results of this pilot study with additional subjects (n=15 vs 7) and time points 
tested (t=8 vs 5) (Fig. 1A). The expression of the three target genes exhibited a significant 
maximum decrease 9 days (P<0.05) after blood transfusion. The diminution of the number of 
copies was also significant at 15 days for ALAS2 and SLC4A1, and at 6 days for SLC4A1. 
These results corroborate the pilot study and certify that the decrease of gene expression 
actually begins 6 days after the reinfusion of one’s own blood. Because ABT could be 
performed few days (1-2 days) before an anti-doping control, other biomarkers such as 
circulating miRNAs could complement this detection strategy [3]. After saline infusion, the 
number of transcripts of the three genes did not vary substantially and remained constant 
throughout the time points (Fig. 1B). Finally, the expression of the housekeeping genes (TBP, 
MRFAP1, ACTR10) used for normalization demonstrated no variation and was uniform 
among the subjects (data not shown). 
Interestingly, the results obtained with the RT-qPCR correlated with those of Nanostring 
nCounter technology (ALAS2, r=0.81; CA1, r=0.88; SLC4A1, r=0.7) (Fig. 2) suggesting that 
both medium-throughput mRNA abundance measurement technologies are robust and 
sensitive for quantitation of reticulocytes’ mRNA. While RT-qPCR analysis is less 
expensive, can profile smaller subset of specific genes such as candidate gene validation and 
is considered as the gold standard for nucleic acid quantification, Nanostring technology does 
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not necessitate reverse transcription and has the ability to profile directly Tempus tubes lysed 
whole blood without any purification steps [9]. 
The reinfusion of one’s own blood triggered a decline of the erythropoietic activity with a 
diminution of Ret% being maximal at 9 days [4]. ABT also produced a similar, although non-
significant, decrease in IRF with a comparable maximal decrease at 9 days (Fig. 3). The 
measure of this parameter exhibited some variability for several volunteers which could be 
rationalized by the absence of normalization in comparison with gene expression. However, 
the variability of these individuals did not influence the overall trend after autologous 
transfusion. Both hematological parameters fluctuate in a similar manner to that of the three 
candidate genes investigated. 
Depending on the maturation stage, reticulocytes contains variable amounts of RNA. They 
are thus divided into low- (LFR), middle- (MFR), and high-fluorescence reticulocytes (HFR) 
populations, of which the HFR fraction includes the most immature reticulocytes [10]. 
Although not fully exploited in anti-doping context, IRF appeared as a particular sensitive 
indicator of bone marrow function and of erythropoietic status in clinic as it includes a count 
of the most immature reticulocytes [11, 12]. Pearson’s correlation between the genes, Ret%, 
and IRF was calculated, and the level of significance determined. A stronger correlation 
between IRF and ALAS2, CA1, and SLC4A1 (Fig. 3) was discovered than for Ret% and these 
three genes (Fig. S1). This can be easily explained by the more abundant RNA content in IRF 
compared to Ret%, which influence greatly the gene expression analysis. 
Although the gene expression significantly correlates with IRF, the magnitude of the changes 
in the number of transcripts was more significant than that of IRF or Ret%. It suggests that in 
response to ABT, the copies remaining in immature RBCs reflect more substantially the bone 
marrow activity than variations of IRF or Ret%. Indeed, ALAS2, CA1, and SLC4A1 genes all 
code for proteins implicated in reticulocyte and erythrocyte metabolism and are thus specific 
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to these sorts of cells and to erythropoiesis [13-15]. It suggests that transcriptomic biomarkers 
might be promising complements to hematological parameters of the ABP in a longitudinal 
monitoring for the detection of transfusion. Moreover, as demonstrated by Durussel et al., 
these genes might also serve as biomarkers of rHuEPO administration [8]. 
However, to ensure the specificity of the genes’ response to ABT and a possible integration 
into the adaptive model of the ABP, the impact of intrinsic and extrinsic factors such as 
altitude exposure or physical exercise must be fully characterized. Because the genes’ 
functions are closely related to reticulocytes’ metabolism, the influence of those confounding 
factors on IRF measurement should also be valuable for the transcriptomic biomarkers. 
In conclusion, our results confirm and consolidate that autologous blood transfusion triggers 
a down-regulation of genes implicated in reticulocytes life cycle. The decrease of ALAS2, 
CA1, and SLC4A1 expression correlated better with IRF than with Ret%. This stronger 
correlation could be explained by the higher amount of RNA contained in IRF compared to 
Ret%. The fluctuations of the number of transcripts seemed also more important than that of 
IRF or Ret%, suggesting that combined with those markers, they can improve the sensitivity 
of ABT detection. 
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Figure 1. A: Transfusion phase. Relative expression of ALAS2, CA1, and SLC4A1 before 
(D-4 and D-1) and 1, 2, 3, 6, 9, 15 days after autologous blood transfusion (n=15). Dashed 
line indicates blood transfusion. Data were normalized to the corresponding levels of 
housekeeping genes (HK: TBP, MRFAP1, ACTR10). The Y axis represents log2-transformed 
relative expression of the genes. Grey lines indicate individual monitoring of gene expression 
and black lines indicate mean (SE) of the 15 independent subjects. *P  0.05; *** P  
0.001, statistically significant difference compared with baseline values (mean of the data 
from 1 and 4 days pre-transfusion). B: Saline phase. Relative expression of ALAS2, CA1, and 
SLC4A1 before (D-4 and D-1) and 1, 2, 3, 6, and 9 days after saline infusion (n=14). Dashed 
line indicates saline infusion. Data were normalized to the corresponding levels of 
housekeeping genes (HK: TBP, MRFAP1, ACTR10). The Y axis represents log2-transformed 
relative expression of the genes. Grey lines indicate individual monitoring of gene expression 
and black lines indicate mean (SE) of the 14 independent subjects. No statistically 
significant difference was observed between time points. 
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Figure 2. Correlation between Nanostring nCounter system and RT-qPCR results after 
autologous blood transfusion. A: ALAS2. Pearson correlation of Nanostring and RT-qPCR 
results (Pearson r=0.81; P<0.0001; n=35). X axis represents the log2-relative expression of 
ALAS2 (RT-qPCR) and Y axis represents the log2-normalized mRNA counts of the gene 
(Nanostring). B: CA1. Pearson correlation of Nanostring and RT-qPCR results (Pearson 
r=0.88; P<0.0001; n=35). X axis represents the log2-relative expression of CA1(RT-qPCR) 
and Y axis represents the log2-normalized mRNA counts of the gene (Nanostring). C: 
SLC4A1. Pearson correlation analysis of Nanostring and RT-qPCR results (Pearson r=0.7; 
P<0.0001; n=35). X axis represents the log2-relative expression of SLC4A1(RT-qPCR) and Y 
axis represents the log2-normalized mRNA counts of the gene (Nanostring). 
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Figure 3. A: Impact of transfusion on IRF. Longitudinal monitoring of IRF before (D-4 
and D-1) and 1, 2, 3, 6, 9, 15 days after autologous blood transfusion (n=15). Dashed line 
indicates blood transfusion. Grey lines indicate individual monitoring of IRF and black line 
indicates mean (SE) of the 15 independent subjects. B: Relationship of IRF and ALAS2 
after ABT. C: Relationship of IRF and CA1 after ABT. D: Relationship of IRF and 
SLC4A1 after ABT. Line represents linear regression of data. X axis represents relative 
expression of the gene and Y axis represents IRF (%). 
